Mohammad Khobreh

Mohammad Khobreh is a highly experienced professional who holds various positions in multiple companies. Currently serving as a Managing Partner and Co-founder at NG Bio, Partner and Investment Committee Member at One Rosemond, Board Member at Bastion Therapeutics, Investor at LightOx and Abselion, Founder and CEO at Piccadilly Prime Ltd., Investor and Board Member at Day Pharmaceutical Complex and QMAB, and Board Member at Lian Chemical and Behnan Gandom. Mohammad holds a Master's degree in Risk Management from Bayes Business School, with previous education in Corporate Law and Governance from The London School of Economics and Political Science, and A-Levels from DLD College London.